Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
15
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Pena Luis C. | President & CEO, Director | 8 | $0 | $550.7K | 2026-09-30 |
| Carver Kyle | Chief Financial Officer | 9 | $13.3K | $415.1K | 2026-07-08 |
| KIRSCH ARTHUR S | Director | 3 | $133.0K | $0 | 2026-07-07 |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | 11 | $0 | $412.9K | 2026-06-22 |
| Drew Janice Suzann | EVP, Operations | 10 | $0 | $452.6K | 2026-06-22 |
| Cohen David E | Director | 6 | $0 | $123.1K | 2026-06-02 |
| MCGRAW BENJAMIN F III | Director | 2 | $0 | $0 | 2026-06-02 |
| Moss Gregory S. | Chief Business & Legal Officer | 8 | $0 | $324.7K | 2026-05-28 |
| Bauer Eugene | Chief Medical Officer | 6 | $0 | $0 | 2026-04-16 |
| Verduyn-van Weegen Felice Isabel | Director, 10% Owner | 6 | $25.00M | $0 | 2026-02-17 |
| LSP 7 Cooperative UA | Director, 10% Owner | 6 | $25.00M | $0 | 2026-02-17 |
| RA Capital Healthcare Fund LP | Director | 1 | $0 | $0 | 2026-02-17 |
| Hopfner Robert Lorne | Director, 10% Owner | 15 | $17.4K | $0 | 2025-12-19 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | Director, 10% Owner | 12 | $0 | $0 | 2025-11-07 |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | 6 | $20.00M | $0 | 2025-11-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Pena Luis C. | President & CEO, Director | A Award | 2026-09-30 | 2026-10-15 | 1,115 | $7.02 | $7.8K | 631,573 | SEC↗ |
| Carver Kyle | Chief Financial Officer | P Buy | 2026-07-08 | 2026-07-10 | 1,000 | $13.26 | $13.3K | 60,335 | SEC↗ |
| KIRSCH ARTHUR S | Director | P Buy | 2026-07-07 | 2026-07-08 | 10,000 | $13.30 | $133.0K | 10,000 | SEC↗ |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | M Exercise deriv | 2026-06-22 | 2026-06-24 | 1,488 | — | $0 | 27,842 | SEC↗ |
| Drew Janice Suzann | Chief of Dev. Operations | M Exercise deriv | 2026-06-22 | 2026-06-24 | 3,839 | — | $0 | 53,795 | SEC↗ |
| Drew Janice Suzann | Chief of Dev. Operations | M Exercise deriv | 2026-06-22 | 2026-06-24 | 16,161 | — | $0 | 39,321 | SEC↗ |
| Pena Luis C. | President & CEO | S Sale | 2026-06-22 | 2026-06-24 | 7,438 | $22.71 | $168.9K | 630,458 | SEC↗ |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | S Sale | 2026-06-22 | 2026-06-24 | 1,488 | $22.50 | $33.5K | 46,403 | SEC↗ |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | M Exercise | 2026-06-22 | 2026-06-24 | 1,488 | $3.84 | $5.7K | 47,891 | SEC↗ |
| Drew Janice Suzann | Chief of Dev. Operations | M Exercise | 2026-06-22 | 2026-06-24 | 3,839 | $3.84 | $14.7K | 71,633 | SEC↗ |
| Drew Janice Suzann | Chief of Dev. Operations | S Sale | 2026-06-22 | 2026-06-24 | 20,000 | $22.63 | $452.6K | 67,794 | SEC↗ |
| Drew Janice Suzann | Chief of Dev. Operations | M Exercise | 2026-06-22 | 2026-06-24 | 16,161 | $2.99 | $48.3K | 87,794 | SEC↗ |
| Cohen David E | Director | A Award deriv | 2026-06-02 | 2026-06-03 | 15,673 | — | $0 | 15,673 | SEC↗ |
| KIRSCH ARTHUR S | Director | A Award deriv | 2026-06-02 | 2026-06-03 | 15,673 | — | $0 | 15,673 | SEC↗ |
| MCGRAW BENJAMIN F III | Director | A Award deriv | 2026-06-02 | 2026-06-03 | 15,673 | — | $0 | 15,673 | SEC↗ |
| Cohen David E | Director | S Sale | 2026-06-02 | 2026-06-03 | 600 | $21.38 | $12.8K | 17,609 | SEC↗ |
| Cohen David E | Director | S Sale | 2026-06-02 | 2026-06-03 | 5,456 | $20.21 | $110.3K | 18,209 | SEC↗ |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | M Exercise deriv | 2026-06-01 | 2026-06-03 | 13,512 | — | $0 | 29,330 | SEC↗ |
| Pena Luis C. | President & CEO | S Sale | 2026-06-01 | 2026-06-03 | 16,787 | $22.74 | $381.7K | 637,896 | SEC↗ |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | S Sale | 2026-06-01 | 2026-06-03 | 16,687 | $22.74 | $379.5K | 46,403 | SEC↗ |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | M Exercise | 2026-06-01 | 2026-06-03 | 13,512 | $3.84 | $51.9K | 63,090 | SEC↗ |
| Carver Kyle | Chief Financial Officer | M Exercise deriv | 2026-05-28 | 2026-06-01 | 15,000 | — | $0 | 96,731 | SEC↗ |
| Moss Gregory S. | Chief Business & Legal Offic | M Exercise deriv | 2026-05-28 | 2026-06-01 | 14,223 | — | $0 | 47,845 | SEC↗ |
| Carver Kyle | Chief Financial Officer | S Sale | 2026-05-28 | 2026-06-01 | 18,175 | $22.84 | $415.1K | 59,335 | SEC↗ |
| Carver Kyle | Chief Financial Officer | M Exercise | 2026-05-28 | 2026-06-01 | 15,000 | $2.99 | $44.9K | 77,510 | SEC↗ |
| Moss Gregory S. | Chief Business & Legal Offic | S Sale | 2026-05-28 | 2026-06-01 | 14,223 | $22.83 | $324.7K | 60,835 | SEC↗ |
| Moss Gregory S. | Chief Business & Legal Offic | M Exercise | 2026-05-28 | 2026-06-01 | 14,223 | $1.71 | $24.3K | 75,058 | SEC↗ |
| Pena Luis C. | President & CEO | A Award deriv | 2026-04-16 | 2026-04-17 | 291,420 | — | $0 | 291,420 | SEC↗ |
| Moss Gregory S. | Chief Business & Legal Offic | A Award deriv | 2026-04-16 | 2026-04-17 | 115,279 | — | $0 | 115,279 | SEC↗ |
| Carver Kyle | Chief Financial Officer | A Award deriv | 2026-04-16 | 2026-04-17 | 98,946 | — | $0 | 98,946 | SEC↗ |
| Bauer Eugene | Chief Medical Officer | A Award deriv | 2026-04-16 | 2026-04-17 | 51,117 | — | $0 | 51,117 | SEC↗ |
| Drew Janice Suzann | Chief of Dev. Operations | A Award deriv | 2026-04-16 | 2026-04-17 | 73,892 | — | $0 | 73,892 | SEC↗ |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | A Award deriv | 2026-04-16 | 2026-04-17 | 69,315 | — | $0 | 69,315 | SEC↗ |
| RA Capital Healthcare Fund LP | Director | A Award | 2026-02-17 | 2026-02-17 | 35,868 | $27.88 | $1000.0K | 2,710,293 | SEC↗ |
| Verduyn-van Weegen Felice Isab | Director, 10% Owner | A Award | 2026-02-17 | 2026-02-18 | 358,680 | $27.88 | $10.00M | 5,288,313 | SEC↗ |
| LSP 7 Cooperative UA | Director, 10% Owner | A Award | 2026-02-17 | 2026-02-19 | 358,680 | $27.88 | $10.00M | 5,288,313 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | P Buy | 2025-12-19 | 2025-12-22 | 1,000 | $17.35 | $17.4K | 4,026 | SEC↗ |
| Bauer Eugene | Chief Medical Officer | F Tax w/h | 2025-12-09 | 2025-12-11 | 1,478 | $17.84 | $26.4K | 270,818 | SEC↗ |
| Carver Kyle | Chief Financial Officer | F Tax w/h | 2025-12-09 | 2025-12-11 | 13,290 | $17.84 | $237.1K | 62,510 | SEC↗ |
| Drew Janice Suzann | EVP, Operations | F Tax w/h | 2025-12-09 | 2025-12-11 | 5,074 | $17.84 | $90.5K | 67,794 | SEC↗ |
| Moss Gregory S. | Chief Business & Legal Offic | F Tax w/h | 2025-12-09 | 2025-12-11 | 13,624 | $17.84 | $243.1K | 60,835 | SEC↗ |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | F Tax w/h | 2025-12-09 | 2025-12-11 | 7,513 | $17.84 | $134.0K | 49,578 | SEC↗ |
| Pena Luis C. | President & CEO | F Tax w/h | 2025-12-09 | 2025-12-11 | 28,138 | $17.84 | $502.0K | 654,683 | SEC↗ |
| Bauer Eugene | Chief Medical Officer | A Award deriv | 2025-12-08 | 2025-12-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Bauer Eugene | Chief Medical Officer | C Conversion deriv | 2025-11-07 | 2025-11-12 | 12,500 | — | $0 | 0 | SEC↗ |
| Bauer Eugene | Chief Medical Officer | C Conversion deriv | 2025-11-07 | 2025-11-12 | 206,355 | — | $0 | 0 | SEC↗ |
| Carver Kyle | Chief Financial Officer | C Conversion deriv | 2025-11-07 | 2025-11-12 | 25,000 | — | $0 | 0 | SEC↗ |
| Cohen David E | Director | C Conversion deriv | 2025-11-07 | 2025-11-12 | 51,588 | — | $0 | 0 | SEC↗ |
| Drew Janice Suzann | EVP, Operations | C Conversion deriv | 2025-11-07 | 2025-11-12 | 12,500 | — | $0 | 0 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 313,571 | — | $0 | 0 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 313,571 | — | $0 | 0 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 2,104,740 | — | $0 | 0 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 1,895,260 | — | $0 | 0 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 2,508,575 | — | $0 | 0 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 2,582,243 | — | $0 | 0 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 3,572,816 | — | $0 | 0 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 7,145,647 | — | $0 | 0 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 25,790 | — | $0 | 0 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 7,230,283 | — | $0 | 0 | SEC↗ |
| Moss Gregory S. | Chief Business & Legal Offic | C Conversion deriv | 2025-11-07 | 2025-11-12 | 25,000 | — | $0 | 0 | SEC↗ |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | C Conversion deriv | 2025-11-07 | 2025-11-12 | 25,000 | — | $0 | 0 | SEC↗ |
| Pena Luis C. | President & CEO | C Conversion deriv | 2025-11-07 | 2025-11-12 | 206,355 | — | $0 | 0 | SEC↗ |
| Verduyn-van Weegen Felice Isab | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 15,493,466 | — | $0 | 0 | SEC↗ |
| Verduyn-van Weegen Felice Isab | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 6,585,011 | — | $0 | 0 | SEC↗ |
| Verduyn-van Weegen Felice Isab | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 5,090,000 | — | $0 | 0 | SEC↗ |
| LSP 7 Cooperative UA | 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 6,585,011 | — | $0 | 0 | SEC↗ |
| LSP 7 Cooperative UA | 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 15,493,466 | — | $0 | 0 | SEC↗ |
| LSP 7 Cooperative UA | 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 5,090,000 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 5,889,699 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 12,924,620 | — | $0 | 0 | SEC↗ |
| Pivotal bioVenture Partners Fu | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 313,571 | — | $0 | 0 | SEC↗ |
| Pivotal bioVenture Partners Fu | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 313,571 | — | $0 | 0 | SEC↗ |
| Pivotal bioVenture Partners Fu | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 2,508,575 | — | $0 | 0 | SEC↗ |
| Pivotal bioVenture Partners Fu | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 7,145,647 | — | $0 | 0 | SEC↗ |
| Pivotal bioVenture Partners Fu | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 3,572,816 | — | $0 | 0 | SEC↗ |
| Pivotal bioVenture Partners Fu | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 2,582,243 | — | $0 | 0 | SEC↗ |
| Pivotal bioVenture Partners Fu | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 7,230,283 | — | $0 | 0 | SEC↗ |
| Pivotal bioVenture Partners Fu | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 1,895,260 | — | $0 | 0 | SEC↗ |
| Pivotal bioVenture Partners Fu | Director, 10% Owner | C Conversion deriv | 2025-11-07 | 2025-11-12 | 2,104,740 | — | $0 | 0 | SEC↗ |
| Bauer Eugene | Chief Medical Officer | C Conversion | 2025-11-07 | 2025-11-12 | 25,812 | — | $0 | 272,296 | SEC↗ |
| Carver Kyle | Chief Financial Officer | C Conversion | 2025-11-07 | 2025-11-12 | 3,175 | — | $0 | 75,800 | SEC↗ |
| Cohen David E | Director | C Conversion | 2025-11-07 | 2025-11-12 | 6,056 | — | $0 | 23,665 | SEC↗ |
| Drew Janice Suzann | EVP, Operations | C Conversion | 2025-11-07 | 2025-11-12 | 1,587 | — | $0 | 72,868 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | C Conversion | 2025-11-07 | 2025-11-12 | 1,632,441 | — | $0 | 1,632,441 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | C Conversion | 2025-11-07 | 2025-11-12 | 294,502 | — | $0 | 294,502 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | C Conversion | 2025-11-07 | 2025-11-12 | 1,441,032 | — | $0 | 1,441,032 | SEC↗ |
| Hopfner Robert Lorne | Director, 10% Owner | C Conversion | 2025-11-07 | 2025-11-12 | 3,026 | — | $0 | 3,026 | SEC↗ |
| Moss Gregory S. | Chief Business & Legal Offic | C Conversion | 2025-11-07 | 2025-11-12 | 3,175 | — | $0 | 3,175 | SEC↗ |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | C Conversion | 2025-11-07 | 2025-11-12 | 3,175 | — | $0 | 57,091 | SEC↗ |
| Pena Luis C. | President & CEO | C Conversion | 2025-11-07 | 2025-11-12 | 24,225 | — | $0 | 682,821 | SEC↗ |
| Verduyn-van Weegen Felice Isab | Director, 10% Owner | P Buy | 2025-11-07 | 2025-11-12 | 1,562,500 | $16.00 | $25.00M | 4,929,633 | SEC↗ |
| Verduyn-van Weegen Felice Isab | Director, 10% Owner | C Conversion | 2025-11-07 | 2025-11-12 | 3,367,133 | — | $0 | 3,367,133 | SEC↗ |
| LSP 7 Cooperative UA | 10% Owner | P Buy | 2025-11-07 | 2025-11-12 | 1,562,500 | $16.00 | $25.00M | 4,929,633 | SEC↗ |
| LSP 7 Cooperative UA | 10% Owner | C Conversion | 2025-11-07 | 2025-11-12 | 3,367,133 | — | $0 | 3,367,133 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | P Buy | 2025-11-07 | 2025-11-12 | 92,904 | $16.00 | $1.49M | 784,345 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | P Buy | 2025-11-07 | 2025-11-12 | 1,157,096 | $16.00 | $18.51M | 2,674,425 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion | 2025-11-07 | 2025-11-12 | 691,441 | — | $0 | 691,441 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion | 2025-11-07 | 2025-11-12 | 1,517,329 | — | $0 | 1,517,329 | SEC↗ |
| Pivotal bioVenture Partners Fu | Director, 10% Owner | C Conversion | 2025-11-07 | 2025-11-12 | 294,502 | — | $0 | 294,502 | SEC↗ |
| Pivotal bioVenture Partners Fu | Director, 10% Owner | C Conversion | 2025-11-07 | 2025-11-12 | 1,441,032 | — | $0 | 1,441,032 | SEC↗ |
| Pivotal bioVenture Partners Fu | Director, 10% Owner | C Conversion | 2025-11-07 | 2025-11-12 | 1,632,441 | — | $0 | 1,632,441 | SEC↗ |
| Pena Luis C. | President & CEO | A Award deriv | 2025-11-05 | 2025-11-07 | 796,841 | — | $0 | 796,841 | SEC↗ |
| Moss Gregory S. | Chief Business & Legal Offic | A Award deriv | 2025-11-05 | 2025-11-07 | 293,496 | — | $0 | 293,496 | SEC↗ |
| Carver Kyle | Chief Financial Officer | A Award deriv | 2025-11-05 | 2025-11-07 | 279,408 | — | $0 | 279,408 | SEC↗ |
| Drew Janice Suzann | EVP, Operations | A Award deriv | 2025-11-05 | 2025-11-07 | 231,274 | — | $0 | 231,274 | SEC↗ |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | A Award deriv | 2025-11-05 | 2025-11-07 | 179,619 | — | $0 | 179,619 | SEC↗ |
| MCGRAW BENJAMIN F III | Director | A Award deriv | 2025-11-05 | 2025-11-07 | 37,960 | — | $0 | 37,960 | SEC↗ |
| KIRSCH ARTHUR S | Director | A Award deriv | 2025-11-05 | 2025-11-07 | 37,960 | — | $0 | 37,960 | SEC↗ |
| Cohen David E | Director | A Award deriv | 2025-11-05 | 2025-11-07 | 37,960 | — | $0 | 37,960 | SEC↗ |